Electrophysiology Devices Market

Market Inshights

The Electrophysiology Devices Market Will Exhibit Healthy Growth Between 2018 and 2026.

The global electrophysiology devices market was worth $6,513.3 million in 2017 and is expected to be worth $16,730.2 million by 2026. Variables of the market include a globally growing older population base coupled with the rising prevalence of atrial fibrillation (AF) and cardiovascular diseases (CVDs), technological advancements in electrophysiology devices, and the presence of favorable government initiatives. The elderly population is more prone to developing AF and cardiovascular diseases. The World Health Organization (WHO) reported that the global elder population has surged from 841.0 million in 2013 to 962.3 million in 2017 and will surpass 2 billion by the end of 2050.

Currently, the number of individuals suffering from atrial fibrillation across the world is more than 33.5 million. AtriCure, Inc., an atrial fibrillation (AF) treatment devices firm, stated that the U.S. has 6.0 million AF patients who incurred a total cost of US$ 26.0 BN for the disease in 2017, and currently, the country holds more than US$ 1.0 BN in market share for atrial fibrillation. According to the American College of Cardiology (ACC) Foundation, about 422.7 million patients were living with cardiovascular disease in 2015, and around 17.9 million patients died from CVDs in 2016, accounting for 31.0% of all worldwide deaths.

Market Synopsis

The Electrophysiology Laboratory Devices Segment to Command the Market from 2018 to 2026

The electrophysiology laboratory devices segment is anticipated to hold the lion’s share of the market between 2018 and 2026, owing to a surge in the number of electrophysiology labs in developed and developing countries, along with an increased focus on new product launches with technological advances in devices including EP X-ray systems, EP imaging systems, 3D mapping and recording systems, intracardiac echocardiography (ICE) systems, radiofrequency (RF) ablation generators, and electrophysiology remote steering systems. Electrophysiology ablation catheters include those for cryoablation and RF ablation, laser ablation systems, and microwave ablation (MWA) systems.

The atrial fibrillation segment is expected to continue its dominance during the forecast period.

The rising prevalence of atrial fibrillation (Afib), technological developments in atrial fibrillation devices such as novel 3D mapping technology, convergent procedures, the WATCHMAN left atrial appendage closure (LAAC) procedure, and focal impulse and rotor modulation (FIRM) ablation are supporting the governance of this segment in terms of value. Moreover, the increasing adoption of radiofrequency and microwave catheter ablation procedures and the advent of implantable cardiac monitors (ICMs) are likely to support market growth throughout the forecast period.

Because of its supportive healthcare infrastructure and key market players, North America will lead the market in 2017.

North America would continue to hold supremacy throughout the forecast period owing to the presence of major market participants and well-established healthcare infrastructure, the surging number of EP labs, and supportive reimbursement and coverage for electrophysiology procedures in the U.S. and Canada. Asia Pacific is envisaged to display a comparatively higher CAGR during the forecast period, attributed to increasing incidence rates of targeted diseases, growing awareness about EP procedures, and rising spending on healthcare in India, China, and Japan.

The presence of international market players creates market penetration challenges for new entrants.

Key participants in this space are Siemens Healthineers; Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Biosense Webster, Inc. (Johnson & Johnson Services, Inc.); BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; MicroPort Scientific Corporation; CardioFocus, Inc.; and Stereotaxis, Inc. In December 2017, Abbott Laboratories, a global healthcare company, launched the world’s first and only smartphone-compatible insertable cardiac monitor, namely the Confirm Rx insertable cardiac monitor (ICM), in the U.S. This device will assist physicians and cardiologists to remotely identify cardiac arrhythmias. Manufacturers have adopted growth strategies such as new product launches, collaborations and partnerships, divestitures, mergers and acquisitions, and operational and geographical expansion.

In July 2017, BIOTRONIK SE & Co. KG launched Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable cardioverter defibrillator (ICD) systems for atrial diagnostics (without an atrial lead) in the U.S. In May 2015, GE Healthcare and Abbott Laboratories collaborated to provide the heart’s electrical activity data to cardiac electrophysiology labs, wherein GE’s CardioLab sends electrogram signal data to Abbott’s RhythmView mapping software, which assists cardiologists in quickly diagnosing the sources of atrial fibrillation and other heart rhythm disorders.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The electrophysiology devices market concentrates on the qualitative and quantitative analysis of present and future market dynamics. The report involves complete information on the global electrophysiology devices market by segmenting the market on the basis of product, indication, and geography. This report will assist industry investors and associations, medical device companies, venture capitalists, suppliers and distributors of medical devices, research and consulting firms, research and academic institutes, and healthcare professionals (HCPs) in decision-making and strategizing the market position.

The current report also covers a qualitative and quantitative analysis of market variables such as key market drivers, restraints, opportunities, and trends, which convey comprehensive market information about the overall electrophysiology devices market. In addition, the report also embraces a graphical illustration of the competitive landscape based on their market initiatives and strategies, product portfolio, financial information, and key developments. Major market players profiled in this study report are Siemens Healthineers; Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Biosense Webster, Inc. (Johnson & Johnson Services, Inc.); BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; MicroPort Scientific Corporation; CardioFocus, Inc.; and Stereotaxis, Inc.

Chapter 1 Preface
1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approaches Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global ED Market
2.1.1 Global ED Market, by Product, 2017 (US$ Mn)
2.1.2 Global ED Market, by Indication, 2017 (US$ Mn)
2.1.3 Global ED Market, by Geography, 2017 (US$ Mn)

Chapter 3 Market Dynamics
3.1 Introduction
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Globally Growing Elderly Population Coupled With Higher Risk of Developing Targeted Disease
3.2.1.2 Driver 2
3.2.1.3 Driver 3
3.2.1.4 Driver 4
3.2.2 Challenges
3.2.2.1 Challenge 1
3.2.2.2 Challenge 2
3.2.3 Opportunities
3.2.3.1 Opportunity 1
3.2.3.2 Opportunity 2
3.3 Attractive Investment Proposition, by Geography, 2017
3.4 Market Positioning of Key Players, 2017

Chapter 4 Global Electrophysiology Devices (ED) Market, by Product, 2016–2026 (US$ Mn)
4.1 Overview
4.2 Electrophysiology Laboratory Devices
4.2.1 Electrophysiology X-Ray Systems
4.2.2 Electrophysiology Imaging, Mapping & Recording Systems
4.2.3 Intracardiac Echocardiography (ICE) Systems
4.2.4 Radiofrequency (RF) Ablation Generators
4.2.5 Electrophysiology Remote Steering Systems
4.3 Electrophysiology Ablation Catheters
4.4 Electrophysiology Diagnostic Catheters
4.4.1 Fixed Diagnostic Catheters
4.4.2 Steerable Diagnostic Catheters
4.5 Cardiac Monitors
4.6 Cardiac Resynchronization Therapy Devices (CRTs)
4.7 Implantable Cardioverter Defibrillators (ICDs)
4.8 Access Devices
4.9 Left Atrial Appendage (LAA) & Closure Devices

Chapter 5 Global Electrophysiology Devices (ED) Market, by Indication, 2016–2026 (US$ Mn)
5.1 Overview
5.2 Atrial Fibrillation (AF)
5.3 Atrial Flutter (AFL)
5.4 Wolff-Parkinson-White (WPW) Syndrome
5.5 Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
5.6 Others (retinal diseases and optic nerve diseases)

Chapter 6 Global Electrophysiology Devices (ED) Market, by Geography, 2016–2026 (US$ Mn)
6.1 Overview
6.2 North America
6.2.1 North America ED Market, by Product, 2016–2026 (US$ Mn)
6.2.2 North America ED Market, by Indication, 2016–2026 (US$ Mn)
6.2.3 North America ED Market, by Country, 2016–2026 (US$ Mn)
6.2.3.1 U.S.
6.2.3.2 Canada
6.3 Europe ED Market, 2016–2026 (US$ Mn)
6.3.1 Europe ED Market, by Product, 2016–2026 (US$ Mn)
6.3.2 Europe ED Market, by Indication, 2016–2026 (US$ Mn)
6.3.3 Europe ED Market, by Country/Region, 2016–2026 (US$ Mn)
6.3.3.1 U.K.
6.3.3.2 Germany
6.3.3.3 Rest of Europe
6.4 Asia Pacific ED Market, 2016–2026 (US$ Mn)
6.4.1 Asia Pacific ED Market, by Product, 2016–2026 (US$ Mn)
6.4.2 Asia Pacific ED Market, by Indication, 2016–2026 (US$ Mn)
6.4.3 Asia Pacific ED Market, by Country/Region, 2016–2026 (US$ Mn)
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 Rest of Asia Pacific
6.5 Latin America ED Market, 2016–2026 (US$ Mn)
6.5.1 Latin America ED Market, by Product, 2016–2026 (US$ Mn)
6.5.2 Latin America ED Market, by Indication, 2016–2026 (US$ Mn)
6.5.3 Latin America ED Market, by Country/Region, 2016–2026 (US$ Mn)
6.5.3.1 Brazil
6.5.3.2 Mexico
6.5.3.3 Rest of Latin America
6.6 Middle East & Africa ED Market, 2016–2026 (US$ Mn)
6.6.1 Middle East & Africa ED Market, by Product, 2016–2026 (US$ Mn)
6.6.2 Middle East & Africa ED Market, by Indication, 2016–2026 (US$ Mn)
6.6.3 Middle East & Africa ED Market, by Region, 2016–2026 (US$ Mn)
6.6.3.1 GCC
6.6.3.2 Rest of Middle East & Africa

Chapter 7 Company Profiles
7.1 Siemens Healthineers
7.2 Medtronic plc
7.3 Boston Scientific Corporation
7.4 Abbott Laboratories
7.5 Biosense Webster, Inc. (Johnson & Johnson Services, Inc.)
7.6 BIOTRONIK SE & Co. KG
7.7 Nihon Kohden Corporation
7.8 MicroPort Scientific Corporation
7.9 CardioFocus, Inc.
7.10 Stereotaxis, Inc.

List of Figures

FIG. 1 Global Electrophysiology Devices (ED) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global ED Market Segmentation
FIG. 4 Global ED Market, by Product, 2017 (US$ Mn)
FIG. 5 Global ED Market, by Indication, 2017 (US$ Mn)
FIG. 6 Global ED Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key Electrophysiology Devices Manufacturers, 2017
FIG. 9 Global Electrophysiology X-Ray Systems Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 10 Global Electrophysiology Imaging, Mapping & Recording Systems Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 11 Global Intracardiac Echocardiography (ICE) Systems Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 12 Global Radiofrequency (RF) Ablation Generators Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 13 Global Electrophysiology Remote Steering Systems Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 14 Global Electrophysiology Ablation Catheters Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 15 Global Fixed Diagnostic Catheters Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 16 Global Steerable Diagnostic Catheters Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 17 Global Cardiac Monitors Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 18 Global Cardiac Resynchronization Therapy Devices (CRTs) Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 19 Global Implantable Cardioverter Defibrillators (ICDs) Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 20 Global Access Devices Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 21 Global Left Atrial Appendage (LAA) & Closure Devices Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 22 Global Atrial Fibrillation (AF) Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 23 Global Atrial Flutter (AFL) Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 24 Global Wolff-Parkinson-White (WPW) Syndrome Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 25 Global Atrioventricular Nodal Reentrant Tachycardia (AVNRT) Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 26 Global Others Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
FIG. 27 U.S. ED Market, 2016–2026 (US$ Mn)
FIG. 28 Canada ED Market, 2016–2026 (US$ Mn)
FIG. 29 U.K. ED Market, 2016–2026 (US$ Mn)
FIG. 30 Germany ED Market, 2016–2026 (US$ Mn)
FIG. 31 Rest of Europe ED Market, 2016–2026 (US$ Mn)
FIG. 32 Japan ED Market, 2016–2026 (US$ Mn)
FIG. 33 China ED Market, 2016–2026 (US$ Mn)
FIG. 34 Rest of Asia Pacific ED Market, 2016–2026 (US$ Mn)
FIG. 35 Brazil ED Market, 2016–2026 (US$ Mn)
FIG. 36 Mexico ED Market, 2016–2026 (US$ Mn)
FIG. 37 Rest of Latin America ED Market, 2016–2026 (US$ Mn)
FIG. 38 GCC ED Market, 2016–2026 (US$ Mn)
FIG. 39 Rest of Middle East & Africa ED Market, 2016–2026 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Electrophysiology Devices (ED) Market (US$ Mn)
TABLE 2 Global ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 3 Global Electrophysiology Laboratory Devices Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
TABLE 4 Global Electrophysiology Diagnostic Catheters Market for Electrophysiology Devices, 2016–2026 (US$ Mn)
TABLE 5 Global ED Market, by Indication, 2016–2026 (US$ Mn)
TABLE 6 Global ED Market, by Geography, 2016–2026 (US$ Mn)
TABLE 7 North America ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 8 North America ED Market, by Indication, 2016–2026 (US$ Mn)
TABLE 9 North America ED Market, by Country, 2016–2026 (US$ Mn)
TABLE 10 Europe ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 11 Europe ED Market, by Indication, 2016–2026 (US$ Mn)
TABLE 12 Europe ED Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 13 Latin America ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 14 Latin America ED Market, by Indication, 2016–2026 (US$ Mn)
TABLE 15 Latin America ED Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 16 Asia Pacific ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 17 Asia Pacific ED Market, by Indication, 2016–2026 (US$ Mn)
TABLE 18 Asia Pacific ED Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 19 Latin America ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 20 Latin America ED Market, by Indication, 2016–2026 (US$ Mn)
TABLE 21 Latin America ED Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 22 Middle East & Africa ED Market, by Product, 2016–2026 (US$ Mn)
TABLE 23 Middle East & Africa ED Market, by Region, 2016–2026 (US$ Mn)
TABLE 24 Siemens Healthineers: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 25 Medtronic plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 26 Boston Scientific Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Overview/Key Developments)
TABLE 27 Abbott Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 28 Biosense Webster, Inc. (Johnson & Johnson Services, Inc.): Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 29 BIOTRONIK SE & Co. KG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 30 Nihon Kohden Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 31 MicroPort Scientific Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 32 CardioFocus, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)
TABLE 33 Stereotaxis, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Developments)